Skip to Main Content

Screening In Anticipation of Future Research

Conditions

Hepatitis | HIV/AIDS | Immune System | Infectious Diseases

What is the purpose of this trial?

This is a blood test screening protocol to test for the human immunodeficiency virus (HIV), Hepatitis  B (HBV), and Hepatitis C (HCV) infection in anticipation of future research on the blood through the Yale Liver Center Patient Registry and Serum/Tissue Bank. The tests are required because the researchers need to know that the samples are safe to handle and because these viruses can change how the cells in your blood work and they may then not be truly representative of the cells that researchers are studying. 

  • Trial with
    Cystic Fibrosis Foundation
  • Start Date
    10/24/2017
  • End Date
    12/30/2018
Trial Image

For more information about this study, contact:

Randolph de la Rosa Rodriguez

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8348

  • Last Updated
    06/22/2018
  • Study HIC
    #2000021443